Saliva Cortisol and Yawning as a Predictor of Neurological Disease
Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 33093
Saliva Cortisol and Yawning as a Predictor of Neurological Disease

Authors: Simon B. N. Thompson

Abstract:

Cortisol is important to our immune system, regulates our stress response, and is a factor in maintaining brain temperature. Saliva cortisol is a practical and useful non-invasive measurement that signifies the presence of the important hormone. Electrical activity in the jaw muscles typically rises when the muscles are moved during yawning and the electrical level is found to be correlated with the cortisol level. In two studies using identical paradigms, a total of 108 healthy subjects were exposed to yawning-provoking stimuli so that their cortisol levels and electrical nerve impulses from their jaw muscles was recorded. Electrical activity is highly correlated with cortisol levels in healthy people. The Hospital Anxiety and Depression Scale, Yawning Susceptibility Scale, General Health Questionnaire, demographic, health details were collected and exclusion criteria applied for voluntary recruitment: chronic fatigue, diabetes, fibromyalgia, heart condition, high blood pressure, hormone replacement therapy, multiple sclerosis, and stroke. Significant differences were found between the saliva cortisol samples for the yawners as compared with the non-yawners between rest and post-stimuli. Significant evidence supports the Thompson Cortisol Hypothesis that suggests rises in cortisol levels are associated with yawning. Ethics approval granted and professional code of conduct, confidentiality, and safety issues are approved therein.

Keywords: Cortisol, Diagnosis, Neurological Disease, Thompson Cortisol Hypothesis, Yawning.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1124015

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 1549

References:


[1] S. B. N. Thompson, “The dawn of the yawn: is yawning a warning? Linking neurological disorders.” Medical Hypotheses, vol. 75, pp. 630–633, 2010.
[2] S. B. N. Thompson, “Yawning,” in S. B. N. Thompson (Ed.), Trauma psychology. Clinical case histories, reviews, research, Portsmouth: Blackwell-Yale-Academic, 2016, pp. 355–360.
[3] S. B. N. Thompson, P. Bishop, “Born to yawn? Understanding yawning as a warning of the rise in cortisol levels: randomized trial,” Interactive Journal of Medical Research, vol. 1, no. 2, part e4, pp. 1–9, 2012.
[4] R. F. Vining, R. A. McGinley, J. J. Maksvytis, K. Y. Ho, “Salivary cortisol: a better measure of adrenal cortisol function than serum cortisol,” Annals of Clinical Biochemistry, vol. 20, no. 6, pp. 329–335, 1983.
[5] S. B. N. Thompson, “Health psychology intervention – identifying early symptoms in neurological disorders,” International Science Index, vol. 17, no. 4, part XXIII, pp. 2639–2643, 2015.
[6] E. Aardal-Eriksson, B. E. Karlberg, A-C. Holm, “Salivary cortisol – an alternative to serum cortisol determinations in dynamic function tests,” Clinical Chemistry & Laboratory Medicine, vol. 36, no. 4, pp. 215–222, 1998.
[7] M. H. Laudat, S. Cerdas, C. Fournier, B. Guiban, B. Guilhaume, J. P. Luton, “Salivary cortisol measurement: a practical approach to assess pituitary-adrenal function,” Journal of Clinical Endocrinology & Metabolism, vol. 66, pp. 343–348, 1988.
[8] E. Aardal, A-C. Holm, “Cortisol in saliva – reference ranges and relation to cortisol in serum,” European Journal of Clinical Chemistry & Clinical Biochemistry, vol. 33, pp. 927–932, 1995.
[9] B. Karlson, F. Eek, A. M. Hansen, A. H. Garde, P. Ørbæk, “Cortisol variability and self-reports in the measurement of work-related stress,” Stress Health, vol. 26, no. 2, pp. e11–e24, 2011.
[10] S. B. N. Thompson, “This will make you yawn,” New Scientist, vol. 224, no. 3000/3001, pp. 38–39, 2014.
[11] S. B. N. Thompson, L. Zisa, “Ill-health, stress, cortisol levels and yawning,” in S. B. N. Thompson (Ed.), Psychology of trauma: clinical reviews, case histories, research, Portsmouth: Blackwell-Harvard-Academic, 2013, pp. 125–132.
[12] American Association of Endocrine Surgeons, “Cushing’s syndrome (cortisol-producing adrenal tumor),” American Association of Endocrine Surgeons Patient Education Site, 2013. Accessed: 29.09.2015. http://endocrinediseases.org/adrenal/cushings_symptoms.shtml.
[13] S. B. N. Thompson, C. Frankham, P. Bishop, “The art of capturing a yawn using the science of nerve impulses and cortisol levels in a randomized controlled trial. Thompson Cortisol Hypothesis as a potential predictor of neurological impairment,” International Journal of Arts & Sciences, vol. 7, no. 3, pp. 529–543, 2014.
[14] M. J. Vigier (translated by), Les aphorisms d’Hippocrate. Lyon, France: J-A. Huguetan, 1620.
[15] S. B. N. Thompson, “How to catch a yawn: initial observations of a randomized controlled trial,” Neurology, vol. 4, no. 8, pp. 1–8, doi: WMC004371, 2013.
[16] S. B. N. Thompson, “Yawning, fatigue and cortisol: expanding the Thompson Cortisol Hypothesis,” Medical Hypotheses, vol. 83, no. 4, pp. 494–496, doi: 10.1016/j.mehy.2014.08.009, 2014.
[17] S. B. N. Thompson, K. Rose, S. Richer, “Yawning with cortisol: examining the neuroscience behind the Thompson Cortisol Hypothesis for supporting rehabilitation of neurologically impaired individuals,” Journal of Neuroscience & Rehabilitation, vol. 1, no. 1, pp. 1–11, doi: 2014.01.01/2374-9091: SS0003, 2014.
[18] S. B. N. Thompson, “Pathways to yawning: making sense of the Thompson Cortisol Hypothesis,” Medical Research Archives, vol. 3, pp. 1–7, doi: http://dx.doi.org/10.18103/mra.v0i3.135, 2015.
[19] S. B. N. Thompson, “Yawning and cortisol as a potential biomarker for early detection of multiple sclerosis,” International Journal of Medical, Health, Biomedical & Pharmaceutical Engineering, vol. 9, no. 5, pp. 358–362, 2015.
[20] S. B. N. Thompson, S. Richer, “How yawning and cortisol regulates the attentional network,” Journal of Neuroscience & Rehabilitation, vol. 2, no. 1, pp. 1–9, doi: www.sciencescript.org/2374-9091: SS0006, 2015.
[21] G. Abbey, S. B. N. Thompson, T. Hickish, D. Heathcote, “A meta-analysis of prevalence rates and moderating factors for cancer-related post-traumatic stress disorder,” Psycho-Oncology, vol. 23, pp. 1–12, doi: 10.1002/pon.3654, 2014.
[22] S. B. N. Thompson, H. Chinnery, S. Noroozi, B. Dyer, K. Barratt, “Retinoblastoma: identifying the diagnostic signs for early treatment,” International Journal of Neurorehabilitation, vol. 2, no. 2, pp. 1–11, doi: 10.4172/2376-0281.10001360, 2015.
[23] H. Chinnery, S. B N. Thompson, “Retinoblastoma,” in S. B. N. Thompson (Ed.), Trauma psychology. Clinical case histories, reviews, research, Portsmouth: Blackwell-Yale-Academic, 2016, pp. 361–390.
[24] H. L. Chinnery, S. B. N. Thompson, “Sensory compensation in children following vision loss after trauma and disease,” Journal of Clinical Research & Ophthalmology, vol. 2, no. 4, pp. pp. 049–053, 2015.
[25] A. C. Gallup, G. G. Jr. Gallup, “Yawning as a brain cooling mechanism: nasal breathing and forehead cooling diminish the incidence of contagious yawning,” Evolutionary Psychology, vol. 5, no. 1, pp. 92–101, 2007.
[26] A. C. Gallup, G. G. Jr. Gallup, “Yawning and thermoregulation,” Physiology & Behavior, vol. 95, pp. 10–16, 2008.
[27] A. C. Gallup, G. G. Jr. Gallup, F. Cocetta, “Yawning, sleep and symptom relief in patients with multiple sclerosis,” Sleep Medicine, vol. 11, pp. 329–330, 2010.